(Total Views: 543)
Posted On: 07/16/2020 7:54:51 AM
Post# of 145248
![Avatar](https://investorshangout.com/images/ProfileImages/167738657_59587_mando klein.jpg)
Since results for m/m trial are getting closer, why not do a little prediction contest: what will the parameters/results look like?
As a reminder, primary endpoint is
Clinical Improvement as assessed by change in total symptom score (for fever, myalgia, dyspnea and cough) [ Time Frame: Day 14 ]
Note: The total score per patient ranges from 0 to 12 points. Each symptom is graded from 0 to 3. [0=none, 1=mild, 2=moderate, and 3=severe]. Higher scores mean a worse outcome.
Name Placebo (mean) leronlimab (mean)
Baseline Day 14 Baseline Day 14
lorbas 3.8 4.1 3.6 1.7
As a reminder, primary endpoint is
Clinical Improvement as assessed by change in total symptom score (for fever, myalgia, dyspnea and cough) [ Time Frame: Day 14 ]
Note: The total score per patient ranges from 0 to 12 points. Each symptom is graded from 0 to 3. [0=none, 1=mild, 2=moderate, and 3=severe]. Higher scores mean a worse outcome.
Name Placebo (mean) leronlimab (mean)
Baseline Day 14 Baseline Day 14
lorbas 3.8 4.1 3.6 1.7
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)